Nathalie BENDRISS-VERMARE

64
Documents

Publications

Publications

Image document

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2

Candice Sakref , Alexis Saby , Céline Rodriguez , Maude Ardin , Lyvia Moudombi et al.
Nature Communications, 2025, 16 (1), pp.3045. ⟨10.1038/s41467-025-58220-8⟩
Article dans une revue hal-05021654 v1
Image document

Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients

Stéphane Dalle , Estelle Verronese , Axelle N’kodia , Christine Bardin , Céline Rodriguez et al.
OncoImmunology, 2024, 13 (1), pp.2372118. ⟨10.1080/2162402X.2024.2372118⟩
Article dans une revue hal-04632685 v1

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

Aurélien Voissière , Carlos Gomez-Roca , Sylvie Chabaud , Céline Rodriguez , Axelle Nkodia et al.
Science Translational Medicine, 2024, 16 (731), ⟨10.1126/scitranslmed.add1834⟩
Article dans une revue hal-04999897 v1

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

Aurélien Voissière , Carlos Gomez-Roca , Sylvie Chabaud , Céline Rodriguez , Axelle Nkodia et al.
Science Translational Medicine, 2024, 16 (731), ⟨10.1126/scitranslmed.add1834⟩
Article dans une revue hal-04645010 v1

Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche

Yohan Gerber-Ferder , Jason Cosgrove , Aleria Duperray-Susini , Yoann Missolo-Koussou , Marine Dubois et al.
Nature Cell Biology, 2023, 25 (12), pp.1736-1745. ⟨10.1038/s41556-023-01291-w⟩
Article dans une revue hal-04480289 v1

Phenotypes and Functions of Human Dendritic Cell Subsets in the Tumor Microenvironment

Candice Sakref , Nathalie Bendriss-Vermare , Jenny Valladeau-Guilemond
Methods in Molecular Biology, 2023, Methods in Molecular Biology, 2618, pp.17-35. ⟨10.1007/978-1-0716-2938-3_2⟩
Article dans une revue hal-04480198 v1

Isolation and Identification of Dendritic Cell Subsets from Human and Mouse Tumors

Yamila Rocca , Aurélien Voissière , Jenny Valladeau-Guilemond , Nathalie Bendriss-Vermare
Methods in Molecular Biology, 2023, Methods in Molecular Biology, 2618, pp.187-197. ⟨10.1007/978-1-0716-2938-3_14⟩
Article dans une revue hal-04480202 v1
Image document

Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial

Jean-David Fumet , Emilie Lardenois , Isabelle Ray-Coquard , Philipp Harter , Florence Joly et al.
Cancers, 2022, 14 (5), pp.1189. ⟨10.3390/cancers14051189⟩
Article dans une revue hal-03769697 v1
Image document

ZEB1 transcription factor promotes immune escape in melanoma

Maud Plaschka , Valentin Benboubker , Maxime Grimont , Justine Berthet , Laurie Tonon et al.
Journal for Immunotherapy of Cancer, 2022, 10 (3), pp.e003484. ⟨10.1136/jitc-2021-003484⟩
Article dans une revue hal-03769027 v1
Image document

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients

Eleonora Sosa Cuevas , Jenny Valladeau-Guilemond , Stephane Mouret , Benoît Roubinet , Florence de Fraipont et al.
Frontiers in Immunology, 2022, 13, pp.1040600. ⟨10.3389/fimmu.2022.1040600⟩
Article dans une revue hal-04098615 v1

Combinatorial Expression of NK Cell Receptors Governs Cell Subset Reactivity and Effector Functions but Not Tumor Specificity

Yamila Rocca , Kevin Pouxvielh , Marie Marotel , Sarah Benezech , Baptiste Jaeger et al.
Journal of Immunology, 2022, 208 (7), pp.1802-1812. ⟨10.4049/jimmunol.2100874⟩
Article dans une revue hal-04098583 v1
Image document

Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80 + PDL1 − )‐pDC subset negatively correlated with clinical outcomes in melanoma patients

Eleonora Sosa Cuevas , Nathalie Bendriss-Vermare , Stephane Mouret , Florence de Fraipont , Julie Charles et al.
Clinical and Translational Immunology, 2022, 11 (5), pp.e1382. ⟨10.1002/cti2.1382⟩
Article dans une revue hal-03783977 v1
Image document

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 + and CD8 + T‐cell protective responses to breast cancer

Raphaël Mattiuz , Carine Brousse , Marc Ambrosini , Jean‐charles Cancel , Gilles Bessou et al.
Clinical and Translational Immunology, 2021, 10, ⟨10.1002/cti2.1305⟩
Article dans une revue hal-03329001 v1
Image document

Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival

Jebrane Bouaoud , Jean-Philippe Foy , Antonin Tortereau , Lucas Michon , Vincent Lavergne et al.
OncoImmunology, 2021, 10 (1), pp.1944554. ⟨10.1080/2162402x.2021.1944554⟩
Article dans une revue hal-03282364 v1
Image document

IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

Margaux Hubert , Elisa Gobbini , Coline Couillault , Thien-Phong Vu Manh , Anne-Claire Doffin et al.
Science Immunology, 2020, 5 (46), pp.eaav3942. ⟨10.1126/sciimmunol.aav3942⟩
Article dans une revue hal-02998632 v1
Image document

CD163 + tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes

Rodrigo Nalio Ramos , Céline Rodriguez , Margaux Hubert , Maude Ardin , Isabelle Treilleux et al.
Clinical and Translational Immunology, 2020, 9 (2), pp.e1108. ⟨10.1002/cti2.1108⟩
Article dans une revue hal-03769582 v1
Image document

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs

Laurissa Ouaguia , Tania Dufeu-Duchesne , Vincent Leroy , Thomas Decaens , Jean-Baptiste Reiser et al.
Clinical and Translational Immunology, 2020, 9 (12), pp.e1208. ⟨10.1002/cti2.1208⟩
Article dans une revue hal-03183870 v1
Image document

Durable and controlled depletion of neutrophils in mice

Gaël Boivin , Julien Faget , Pierre-Benoit Ancey , Aspasia Gkasti , Julie Mussard et al.
Nature Communications, 2020, 11 (1), pp.2762. ⟨10.1038/s41467-020-16596-9⟩
Article dans une revue inserm-02879178 v1

Abstract B84: Decipher the role of IL-33 as an activator of NK cells’ antitumor activity

Anaïs Eberhardt , Elena Blanc , Emilie Lardenois , Sarah Renaudineau , Jennifer Herbulot et al.
Cancer Immunology Research, 2020, 8 (4_Supplement), pp.B84-B84. ⟨10.1158/2326-6074.tumimm18-b84⟩
Article dans une revue hal-04771517 v1
Image document

Inflammasome Deletion Promotes Anti-tumor NK Cell Function in an IL-1/IL-18 Independent Way in Murine Invasive Breast Cancer

Baptiste Guey , Mélanie Bodnar-Wachtel , Annabelle Drouillard , Anaïs Eberhardt , Manon Pratviel et al.
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.01683⟩
Article dans une revue hal-03093037 v1
Image document

BDCA1 + cDC2s, BDCA2 + pDCs and BDCA3 + cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

Eleonora Sosa Cuevas , Laurissa Ouaguia , Stephane Mouret , Julie Charles , Florence Fraipont et al.
Clinical and Translational Immunology, 2020, 9 (11), pp.e1190. ⟨10.1002/cti2.1190⟩
Article dans une revue hal-03329086 v1
Image document

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

Laurissa Ouaguia , Vincent Leroy , Tania Dufeu-Duchesne , David Durantel , Thomas Decaens et al.
Frontiers in Immunology, 2019, 10, pp.112. ⟨10.3389/fimmu.2019.00112⟩
Article dans une revue hal-02361633 v1
Image document

Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses

Margaux Hubert , Elisa Gobbini , Nathalie Bendriss-Vermare , Christophe Caux , Jenny Valladeau-Guilemond
Cancers, 2019, 11 (8), pp.1082. ⟨10.3390/cancers11081082⟩
Article dans une revue hal-03769128 v1
Image document

Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection

Suzanne Faure-Dupuy , Marion Delphin , Ludovic Aillot , Laura Dimier , Fanny Lebossé et al.
Journal of Hepatology, 2019, 71 (6), pp.1086-1098. ⟨10.1016/j.jhep.2019.06.032⟩
Article dans une revue hal-03315737 v1
Image document

Neutrophil Heterogeneity in Cancer: From Biology to Therapies

Pacôme Lecot , Matthieu Sarabi , Manuela Pereira-Abrantes , Julie Mussard , Leo Koenderman et al.
Frontiers in Immunology, 2019, 10, pp.2155. ⟨10.3389/fimmu.2019.02155⟩
Article dans une revue (article de synthèse) hal-02398993 v1
Image document

Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines

Suzanne Faure-Dupuy , Serena Vegna , Ludovic Aillot , Laura Dimier , Knud Esser et al.
Journal of Innate Immunity, 2018, 10 (4), pp.339-348. ⟨10.1159/000489966⟩
Article dans une revue hal-03315727 v1
Image document

Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells

Ludovic Aillot , Marc Bonnin , Malika Ait-Goughoulte , Nathalie Bendriss-Vermare , Sarah Maadadi et al.
Antimicrobial Agents and Chemotherapy, 2018, 62 (4), pp.1741 - 1758. ⟨10.1128/AAC.01741-17⟩
Article dans une revue inserm-01760408 v1
Image document

Immunothérapie et thérapies ciblées, une combinaison d’avenir dans la lutte contre le cancer

Nathan Andrieu , Nathalie Bendriss-Vermare
Médecine/Sciences, 2018, 34 (10), pp.872-875. ⟨10.1051/medsci/2018217⟩
Article dans une revue hal-02970084 v1

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration

Mathilde Small , Isabelle Treilleux , Coline Couillault , Daniel Pissaloux , Géraldine Picard et al.
Acta Neuropathologica, 2018, 135 (4), pp.569-579. ⟨10.1007/s00401-017-1802-y⟩
Article dans une revue hal-04998090 v1
Image document

Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells

Ivan Hirsch , Ruzena Stranska , Vaclav Janovec , Nathalie Bendriss-Vermare
Frontiers in Immunology, 2017, 8, pp.394. ⟨10.3389/fimmu.2017.00394⟩
Article dans une revue hal-01789674 v1
Image document

BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells

Alexis Combes , Voahirana Camosseto , Prudence N’guessan , Rafael J Argüello , Julie Mussard et al.
Nature Communications, 2017, 8 (1), pp.913. ⟨10.1038/s41467-017-00695-1⟩
Article dans une revue hal-03545468 v1
Image document

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Jean‐philippe Foy , Chloé Bertolus , Marie-Cécile Michallet , Sophie Deneuve , R. Incitti et al.
Annals of Oncology, 2017, 28 (8), pp.1934-1941. ⟨10.1093/annonc/mdx210⟩
Article dans une revue hal-01560943 v1

Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo

Ludovic Moro-Sibilot , Sébastien This , Pascal Blanc , Amelien Sanlaville , Vanja Sisirak et al.
European Journal of Immunology, 2016, 46, pp.354--359. ⟨10.1002/eji.201545977⟩
Article dans une revue hal-01812673 v1

pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation

F.V. Duraes , C. Lippens , K. Steinbach , J. Dubrot , D. Brighouse et al.
Journal of Autoimmunity, 2016, 67, pp.8-18. ⟨10.1016/j.jaut.2015.08.014⟩
Article dans une revue hal-01792631 v1

BAD-LAMP a novel actor of TLR9 trafficking in human plasmacytoid dendritic cells

N. Bendriss-Vermare , P. Pierre , E. Gatti , A. Combes , N'Guessan P. Sari et al.
European Journal of Immunology, 2016, 46 (1, SI), pp.1031
Article dans une revue hal-01438132 v1
Image document

A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage

Colette Dezutter-Dambuyant , Isabelle Durand , Laurent Alberti , Nathalie Bendriss-Vermare , Jenny Valladeau-Guilemond et al.
OncoImmunology, 2015, 5, ⟨10.1080/2162402x.2015.1091146⟩
Article dans une revue hal-03045642 v1

TLR9 transcriptional regulation in response to double-stranded DNA viruses

Claudia Zannetti , Peggy Parroche , Marine Panaye , Guillaume Roblot , Henri Gruffat et al.
Journal of Immunology (Baltimore, Md.: 1950), 2014, 193 (7), pp.3398-3408. ⟨10.4049/jimmunol.1400249⟩
Article dans une revue hal-01911132 v1
Image document

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+T cells by plasmacytoid dendritic cells

Julien Faget , Vanja Sisirak , Jean-Yves Blay , Christophe Caux , Nathalie Bendriss-Vermare et al.
OncoImmunology, 2013, 2, ⟨10.4161/onci.23185⟩
Article dans une revue hal-03045731 v1
Image document

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+regulatory T cells and are associated with poor prognosis in breast cancer patients

Vanja Sisirak , Julien Faget , Nelly Vey , Jean-Yves Blay , Christine Ménétrier-Caux et al.
OncoImmunology, 2013, 2, ⟨10.4161/onci.22338⟩
Article dans une revue hal-03045754 v1
Image document

Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells

Vanja Sisirak , Nelly Vey , Nadège Goutagny , Sarah Renaudineau , Marine Malfroy et al.
International Journal of Cancer, 2013, 133 (3), pp.771 - 778. ⟨10.1002/ijc.28072⟩
Article dans une revue hal-03045770 v1

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis.

Sana Intidhar Labidi-Galy , Isabelle Treilleux , Sophie Goddard-Leon , Jean-Damien Combes , Jean-Yves Blay et al.
OncoImmunology, 2012, 1 (3), pp.380-382. ⟨10.4161/onci.18801⟩
Article dans une revue hal-00724435 v1

Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis.

J. Gillibert-Duplantier , B. Duthey , V. Sisirak , D. Salaün , T. Gargi et al.
Oncogene, 2012, 31 (30), pp.3516-24. ⟨10.1038/onc.2011.525⟩
Article dans une revue hal-00820060 v1
Image document

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

Philippe Cassier , Isabelle Treilleux , Thomas Bachelot , Isabelle Ray-Coquard , Nathalie Bendriss-Vermare et al.
BMC Cancer, 2011, 11 (1), pp.213. ⟨10.1186/1471-2407-11-213⟩
Article dans une revue inserm-00606545 v1

Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.

Sana Intidhar Labidi-Galy , Vanja Sisirak , Pierre Meeus , Michael Gobert , Isabelle Treilleux et al.
Cancer Research, 2011, 71 (16), pp.5423-34. ⟨10.1158/0008-5472.CAN-11-0367⟩
Article dans une revue hal-00849783 v1

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor.

Julie Charles , Jérémy Di Domizio , Dimitri Salameire , Nathalie Bendriss-Vermare , Caroline Aspord et al.
Journal of Investigative Dermatology, 2010, 130 (6), pp.1646-56. ⟨10.1038/jid.2010.24⟩
Article dans une revue inserm-00633157 v1

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response.

Nathalie Bendriss-Vermare , Laurence Chaperot , Michel Peoc'H , Béatrice Vanbervliet , Marie-Christine Jacob et al.
Leukemia, 2004, 18 (9), pp.1491-8. ⟨10.1038/sj.leu.2403452⟩
Article dans une revue inserm-00286469 v1

Regulation of NK cell biology and plasticity in cancer

Nathalie Bendriss-Vermare
11èmes Journée d’Immunologie et Immunothérapie des Cancers (JIIC), Dec 2024, Dijon, France
Communication dans un congrès hal-04967940 v1

IFN-III primes pDCs for TLR7 activation and antagonizes TGF-β and PGE2 mediated-immune suppression

Alexis Saby , Candice Sakref , Céline Rodriguez , Lyvia Moudombi , Aurelien Voissiere et al.
17th International Symposium on Dendritic Cells, Oct 2024, Barcelona (ES), Spain
Communication dans un congrès hal-04944678 v1

Dynamics of innate immune cells across tumorigenesis

Nathalie Bendriss-Vermare
FAPESP Brazil-France Health Workshop, Jun 2024, Sao paulo, Brazil
Communication dans un congrès hal-04967996 v1

Regulation of NK cell activation and plasticity by cytokines

Nathalie Bendriss-Vermare
NK & ILC meeting, Oct 2024, LYON (ENS et Lyon 3), France
Communication dans un congrès hal-04998366 v1

Le partenariat entre les cellules dendritiques et les lymphocytes T CD8 améliore la survie des enfants atteints par un neuroblastome

Alexia Gazeu , Cécile Picard , Benoît Dumont , Aurélien Voissiere , Justine Berthet et al.
Carrefour pathologie, Nov 2023, Paris, France
Communication dans un congrès hal-04890898 v1

The CSF-1R inhibitor Pexidartinib impacts dendritic cell differentiation through inhibition of FLT3 signaling and may antagonize the effect of durvalumab in patients with advanced cancer – results from a phase 1 study

Céline Rodriguez , Aurélien Voissiere , Axelle Nkodia , Carlos Alberto Gomez-Roca , Sylvie Chabaud et al.
26e congrès annuel de l’AFC à Toulouse, Nov 2023, Toulouse, France
Communication dans un congrès hal-04890819 v1

Conventional Dendritic cells drive the generation of polyfunctional and antitumor ST2+ NK cells

Nathalie Bendriss-Vermare
Club Francophone des Cellules Dendritiques, Dec 2023, Bordeaux, France
Communication dans un congrès hal-04944816 v1

Context- and subset-dependent NK cell activation by interleukin-33 in tumors

Valentin Picant , Lara Revol-Bauz , Aurélien Voissiere , Yamila Rocca , Anais Eberhardt et al.
Annual Joint Meeting SFI-DGfI, Sep 2023, Strasbourg, France
Communication dans un congrès hal-04890839 v1

Conventional Dendritic cells drive the generation of polyfunctional and antitumor ST2+ NK cells

Nathalie Bendriss-Vermare
DC2022 international symposium, Oct 2022, Cairns (Australie), Australia
Communication dans un congrès hal-04944830 v1

Interleukin-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population

Nathalie Bendriss-Vermare
Immune Responses in Cancer and Infection 2022, Jun 2022, Lyon, France
Communication dans un congrès hal-04944851 v1